SelectScience InterviewsSpectroscopy

Mapping Oncological Therapies with MALDI MSI Technology

22 Apr 2019
Mapping Oncological Therapies with MALDI MSI Technology

In this video, discover how the spatial distribution of oncological therapies can be characterized using matrix-assisted laser desorption/ionization mass spectrometric imaging (MALDI MSI) technology. Using the mimetic model protocol and the MALDI SYNAPT G2-Si high definition mass spectrometer from Waters Corporation, Dr. Bindesh Shrestha demonstrates the semi-quantification of the chemotherapy drug, doxorubicin.

This interview was filmed as part of our coverage of AACR 2019 - see other video highlights here >>

Other videos from SelectScience

Links